A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Changes when biosimilar biological products become eligible for Medicare price negotiations.
In the Senate Finance Committee since Sept. 28, 2026, 8 days after it was introduced. Most bills never leave committee.
- INTRODUCEDINTROSEP 28, 2026
- COMMITTEECOMM.IN COMMITTEE
- SENATESENATE—
- HOUSEHOUSE—
- LAWLAW—
What the bill would do, and why it matters
Medicare has rules for when it can negotiate prices for certain medicines. The bill would change when biosimilar biological products become eligible for those negotiations, though the title does not specify how the timing would change.
- INTRODUCED ONLY This bill has been introduced and possibly referred to a committee, but it has not passed any vote. Most introduced bills never become law — they die in committee without a hearing.
- FULL TEXT UNAVAILABLE Congress.gov has not posted the full bill text yet. The analysis is based on the title and metadata only and may miss substantive provisions.
- DATA NOTE No Congressional Research Service summary was available.
- Changes biosimilar negotiation timing
Would change when biosimilar biological products become eligible for Medicare price negotiations. The direction and details of the timing change are not specified in the bill title.
The timing of eligibility determines when Medicare can negotiate prices for biosimilar products. Changing that timing could affect when negotiations—and any resulting price changes—can occur.
Written from the official record.
The path it took, step by step
- IntroducedSEP 28, 2026SENATESEP 28, 2026By Sen. Blackburn with 3 original cosponsorsReferred to Finance
- SAME DAYNOWSenate committeeSEP 28, 2026FINANCE NOWSEP 28, 2026In committee for 8 daysNo hearing yet
- 8 DAYS SO FARPassed the Senate—SENATE FLOOR—Not scheduled
- House committee—HOUSE—
- Passed the House—HOUSE FLOOR—Not scheduled
- Resolve differencesONLY IF NEEDEDBOTH CHAMBERSONLY IF NEEDEDSkipped if the other chamber passes the same text
- Signed into law—PRESIDENT—10 days to sign or veto
- SEP 282026SEP 28, 2026REFERREDRead twice and referred to the Committee on Finance.
- SEP 282026SEP 28, 2026INTRODUCEDSENATEIntroduced in Senate
At day 8, this bill is already older than 3% of the laws passed this Congress were when they were signed.
Where your members stand on it
A coalition from 3 states
Plus the sponsor, a Republican. The smaller side has 1 member.
Plus the sponsor, a Republican. The smaller side has 1 member.
Sen. Blackburn’s record: sponsored 145 bills this Congress. 13 passed the Senate; 1 became law.
- Ted BuddR-NCORIGINAL
- James LankfordR-OKORIGINAL
- Adam B. SchiffD-CAORIGINAL
What readers think
Discussion
Get an alert when it changes stage, gets a floor vote in the Senate, or is signed into law.